Explore 4C-CP | PiHKAL

Cunningham, MJ; Bock, HA; Serrano, IC; Bechand, B; Vidyadhara, DJ; Bonniwell, EM; Lankri, D; Duggan, P; Nazarova, AL; Cao, AB; Calkins, MM; Khirsariya, P; Hwu, C; Katritch, V; Chandra, SS; McCorvy, JD; Sames, D. Pharmacological mechanism of the non-hallucinogenic 5-HT_2A agonist Ariadne and analogs. ACS Chem. Neurosci., 15 Dec 2022, n/a. 15.3 MB. https://doi.org/10.1021/acschemneuro.2c00597 #30 MS,NMR,other

G-4

N-Cyclopropyl-2,5-dimethoxy-4-methylamphetamine · N-cPr-DOM

N-Pentyl-3,4-methylenedioxyamphetamine · MDAM

ETHYL-L · α-Bu-N-Et-MDPEA · α-Butyl-N-ethyl-3,4-methylenedioxyphenethylamine

F-233

4-Cyclopropylmethyl-2,5-dimethoxyamphetamine · DOCPM

3,4-DHO-CPDPA

2769

O-DSMT · O-Desmethyltramadol

Procinolol

Alprenolol

N-(t-Butoxycarbonyl)-N-methylamphetamine · N-t-BOC-MA

2C-E-NPI

Ciramadol · WY-15,705

Lophocerine

2C-E-3PIP

N-Pyrrolidinyl-3,4-DMA